Stay updated with breaking news from Positive Breast. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At the Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit, an expert explained HER2-positive breast cancer and gave an overview of effective treatment options in this space.
BOTHELL - Seagen Inc. today announced data from the Phase 3 HER2CLIMB-02 clinical trial of TUKYSA in combination with the antibody-drug conjugate ado-trastuzumab emtansine . The combination showed...
BOTHELL, Wash.--(BUSINESS WIRE)--Dec 6, 2023--
The total metastatic HER2-positive breast cancer market size in the 7MM was estimated to be nearly USD 2.6 billion in 2022, which is expected to show positive...
AMSBIO has supplied a tailor-made monoclonal antibody (mAB) to TU Dortmund researchers in Germany. Click to read more...